Speech-Language Pathologists in Senatobia, MS Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Sycamore Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 209 Clearview Dr, Senatobia, MS 38668 Phone: 662-292-1024 |
 Mrs. Margaret (lisa) Scott Billingsley, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 503 Southfork Dr, Senatobia, MS 38668 Phone: 662-562-6916 |
Mrs. Samantha Webb, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 329 W Tate St, Senatobia, MS 38668 Phone: 662-292-1024 Fax: 662-796-4740 |
News Archive
Elysium Internet to exhibit direct navigation patient acquisition program
Elysium Internet, Inc., a next generation Local Internet advertising and digital media Company, today announced that it will exhibit its performance based, direct navigation patient acquisition program at the North Carolina Foot and Ankle Society's Winter Seminar, next week.
Preventing falls in older people: an interview with Professor Lindy Clemson
We often think of tripping over a step edge or pathway obstruction but there can be a range of things that can contribute to a fall. One of the most common is that our ability to balance can be reduced. This means that we don't recover from a trip and are at more of a risk of losing our balance.
SynGen announces relocation of corporate headquarters
SynGen, Inc., a company focused on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that it has moved its corporate headquarters to a new location in Sacramento, California. The headquarter's new address is 100 Howe Avenue, Suite 185N, Sacramento, CA 95825-8219. All other contact information, including phone numbers, remains the same.
Completion of first clinical trial of Apatone for cancer treatment
In a significant advancement in the ongoing battle against cancer, a group of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human clinical trial of Apatone®.
Frequent traumatic experiences throughout infancy increase risk of psychosis during adulthood
A research carried out with participation of the University of Granada proves that suffering repeated traumatic experiences throughout infancy and adolescence multiplies by 7 the risk of suffering psychosis during adulthood.
› Verified 3 days ago
Optometrists
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists